Skip to main content
Clinical Trials/CTRI/2024/03/063428
CTRI/2024/03/063428
Not yet recruiting
未知

Identifying responder/non-responder status prior to anti-PD L1 or neo adjuvant/ palliative chemotherapy in Lung and Head and Neck cancers using a novel bioinformatic approach to analyze biomarker data. - NI

Tata Memorial Centre0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxHealth Condition 2: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung
Sponsor
Tata Memorial Centre
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Lung (NSCLC) and oral (OSCC) cancer patients (Histo\-pathologically diagnosed) who are slated to undergo anti\-PD L1/ neoadjuvant or palliative chemotherapy.
  • 2\.Patients can provide sufficient tissues/blood for molecular analysis.
  • 3\.Consent from patients for utilization of their tissues and blood for this study.

Exclusion Criteria

  • 1\.Pregnant women and patients under the age of 18
  • 2\.Those who are unfit to provide biopsy samples as per protocol
  • 3\.Those who refuse to consent to tissues being provided for research as per this protocol

Outcomes

Primary Outcomes

Not specified

Similar Trials